NYSE · USBFinancialsBanking & Credit

U.S. Bancorp financials

$58.78−0.93%
Close Sep 28, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ2 '26
Jun 30
Q1 '26
Mar 31
Q4 '25
Dec 31
Q3 '25
Sep 30
Q2 '25
Jun 30
Q1 '25
Mar 31
Q4 '24
Dec 31
Q3 '24
Sep 30
Q2 '24
Jun 30
Q1 '24
Mar 31
Q4 '23
Dec 31
Q3 '23
Sep 30
Revenue$10.92B$10.84B$10.98B$11.01B$10.53B$10.35B$10.66B$10.78B$10.80B$10.46B$10.38B$10.52B
Gross profit$7.69B$7.26B$7.34B$7.30B$6.97B$6.93B$6.98B$6.83B$6.84B$6.68B$6.73B$7.00B
Gross margin70.4%67.0%66.8%66.3%66.3%66.9%65.4%63.4%63.3%63.9%64.8%66.6%
Operating income$2.72B$2.42B$2.53B$2.53B$2.29B$2.16B$2.11B$2.07B$2.06B$1.67B$1.00B$1.96B
Net income$2.10B$1.84B$1.97B$1.89B$1.73B$1.60B$1.58B$1.60B$1.52B$1.21B$766.0M$1.41B
Net margin19.2%17.0%17.9%17.2%16.5%15.5%14.8%14.8%14.1%11.6%7.4%13.4%
Diluted EPS$1.35$1.18$1.26$1.22$1.11$1.03$1.01$1.03$0.97$0.78$0.49$0.91
EBITDA$2.72B$2.42B$2.53B$2.53B$2.29B$2.16B$2.11B$2.07B$2.06B$1.83B$1.17B$2.24B
Operating cash flow$4.82B$1.34B$2.84B$3.39B$1.91B-$308.0M$4.84B$972.0M$2.87B$2.66B$416.0M$3.87B
Free cash flow$4.82B$1.34B$2.84B$3.39B$1.91B-$308.0M$4.84B$972.0M$2.87B$2.66B$416.0M$3.87B
Diluted shares1,555.0M1,555.0M1,556.0M1,557.0M1,559.0M1,560.0M1,563.0M1,561.0M1,561.0M1,559.0M1,558.0M1,549.0M

Balance sheet

Period endJun 30Mar 31Dec 31Sep 30Jun 30Mar 31
Cash & equivalents$66.49B$48.42B$46.89B$66.64B$57.81B$50.01B
Short-term investments$163.17B$168.91B$167.01B$166.00B$168.46B$164.78B
Total debt$96.01B$79.22B$77.93B$77.98B$79.05B$77.02B
Total assets$725.92B$701.00B$692.35B$695.36B$686.37B$676.49B
Total liabilities$658.02B$634.75B$626.69B$631.56B$624.47B$615.93B
Shareholders' equity$67.89B$66.25B$65.65B$63.80B$61.90B$60.56B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology